​The Mets kicked off the 2026 MLB Draft by selecting Arkansas right-hander Carson Wiggins with the 27th overall pick. Their status at number 27 stems from a high payroll burden that pulled them ten spots from where they would have landed at 17 based on their 2025 record. Wiggins represents a bold, upside-driven wager for a club that has shown a willingness to gamble on premium talent with questions surrounding durability and development.
Wiggins’ on-field resume at Arkansas is limited, though his pedigree speaks loudly. A former highly touted high school recruit from Oklahoma, he debuted for the Razorbacks as a true freshman in Fayetteville, logging 14 relief appearances. In those outings, he saved three games and posted a 3.21 ERA across 14 innings. He struck out 33.9 percent of the batters he faced while issuing walks at a 15.3 percent clip, numbers that hint at the trouble-to-triumph profile scouts chase. The sampling is small, and his college career was abruptly truncated after those 14 appearances due to elbow trouble that ultimately required Tommy John surgery in May 2025. The operation sidelined him for the entire 2026 season, preventing a longer, more telling professional evaluation.
What remains compelling about Wiggins is the potential that still exists when he’s healthy and on the mound. He has flashed electric stuff in the past, including a fastball that has reached triple digits and a wipeout slider that can carry swing-and-miss potential. Yet there isn’t a long track record to lean on from his Razorback days. The combination of a limited college workload, a significant elbow procedure, and a draft-eligible sophomore status makes him a high-risk, high-reward proposition for the Mets. If he can regain pre-injury velocity and command, he could develop into a frontline or near-frontline starter—an outcome that would justify the underslot profile the Mets may be pursuing with him.
Health is the linchpin for Wiggins’ projection. He is now healthy enough to have pitched at the Draft Combine, indicating that he’s past the rehab phase and ready to compete. The Mets, who have prioritized development pipelines in recent drafts, will likely lean on their internal strengths to maximize Wiggins’ potential. Their plan would be to pair cutting-edge development with vigilant workload management, a combination that could help him translate his raw stuff into consistently usable major league offerings.
The decision to draft Wiggins carries a certain strategic texture for the Mets beyond the player himself. With Bo Bichette’s signing, New York forfeited their second-round pick, delaying their next selection until the 92nd overall pick in the third round. That means the Mets won’t add a new pick until the third round, which heightens the importance of every choice they make in the interim. Wiggins’ selection, then, serves as a high-variance, possibly high-impact investment meant to reap dividends down the road if his health holds and his velocity returns.
In evaluating Wiggins, teams will weigh a few key factors: his elite arm speed, the potential for a high-ceiling starter, and the relative risk introduced by his limited college exposure and the lingering questions about durability. The Mets’ willingness to roll the dice on a pitcher with a track record of electric stuff but limited innings mirrors a broader trend in the modern draft, where teams increasingly backtalent with premium upside while managing the medical and workload risks through careful development plans and modern medical insight. Baseball scouts will also monitor his spin rates on breaking balls and his ability to command against higher levels of competition if he progresses into professional assignments.
Looking ahead, Wiggins’ trajectory will hinge on medical clearance, performance recovery, and the ability of the Mets’ development system to unlock his ceiling. If he maintains health, regains peak velocity, and translates his raw stuff into consistent strike-throwing ability, he could join a growing cadre of pitchers who have carved out a significant impact after overcoming early-career medical hurdles. For now, he remains a risk-reward bet with a tantalizing ceiling, chosen by a Mets organization that has shown a willingness to pursue upside even when the path is not straightforward.
As the 2026 draft unfolds for the Mets, their second selection will not come until the 92nd overall pick in the third round due to the Bichette signing. Until then, New York will monitor Wiggins’ development, hoping that his time away from the mound has translated into a healthier, stronger, and more durable arm capable of delivering the kind of velocity and breaking ball development that could make the difference in a high-stakes, upside-driven draft pick.